In my last piece discussing Inovio (NASDAQ:INO) stock, I mentioned reasons to remain positive on the biotech company despite a sharp pullback recently. But it looks like Inovio’s chances for mounting a comeback are slowly slipping away. Source: Ascannio / Shutterstock.com The markets have spoken. They want something concrete from the biotech company before they can
0 Comments
(L-R) Lloyd Blankfein and David Solomon attend NYSCF Annual Summer Cocktail Reception at Private Residence on July 15, 2016 in Sagaponack, NY. Sean Zanni | Patrick McMullan | Getty Images Goldman Sachs is moving to claw back tens of millions of dollars in compensation it’s paid executives including CEO David Solomon and former CEO Lloyd
0 Comments
Prepared by Tara, Senior Analyst at BAD BEAT Investing CSX Corporation’s (CSX) stock has been chugging along as the company is working to get back on track. While things are definitely improving economically, the company is still facing some headwinds, most notably in its coal volumes, and not from general economic pressures. Rail data certainly
0 Comments
JPMorgan’s Business Complete Banking service Source: JP Morgan JPMorgan Chase is making a play to sell more services to millions of American small business owners, pushing into an area pioneered by fintech firms including Square, PayPal and First Data, CNBC has learned. The bank is rolling out a checking account that is paired with a
0 Comments